Susquehanna International Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-36,591
| Closed | -$5.53M | – | 7513 |
|
|
2022
Q3 | $5.53M | Buy |
36,591
+4,596
| +14% | +$695K | ﹤0.01% | 783 |
|
|
2022
Q2 | $4.66M | Buy |
31,995
+17,851
| +126% | +$2.6M | ﹤0.01% | 975 |
|
|
2022
Q1 | $1.68M | Sell |
14,144
-37,306
| -73% | -$4.42M | ﹤0.01% | 2206 |
|
|
2021
Q4 | $7.09M | Buy |
51,450
+19,103
| +59% | +$2.63M | ﹤0.01% | 962 |
|
|
2021
Q3 | $4.49M | Buy |
32,347
+19,078
| +144% | +$2.65M | ﹤0.01% | 1245 |
|
|
2021
Q2 | $1.29M | Sell |
13,269
-59,787
| -82% | -$5.8M | ﹤0.01% | 2639 |
|
|
2021
Q1 | $4.99M | Sell |
73,056
-243,909
| -77% | -$16.7M | ﹤0.01% | 1247 |
|
|
2020
Q4 | $27.2M | Buy |
316,965
+303,400
| +2,237% | +$26M | ﹤0.01% | 335 |
|
|
2020
Q3 | $882K | Buy |
13,565
+9,273
| +216% | +$603K | ﹤0.01% | 2379 |
|
|
2020
Q2 | $314K | Sell |
4,292
-251,450
| -98% | -$18.4M | ﹤0.01% | 3350 |
|
|
2020
Q1 | $8.7M | Buy |
255,742
+85,209
| +50% | +$2.9M | ﹤0.01% | 463 |
|
|
2019
Q4 | $9.28M | Sell |
170,533
-41,812
| -20% | -$2.28M | ﹤0.01% | 559 |
|
|
2019
Q3 | $8.86M | Buy |
212,345
+179,952
| +556% | +$7.51M | ﹤0.01% | 461 |
|
|
2019
Q2 | $1.42M | Sell |
32,393
-193,414
| -86% | -$8.47M | ﹤0.01% | 1634 |
|
|
2019
Q1 | $11.6M | Buy |
225,807
+173,508
| +332% | +$8.93M | ﹤0.01% | 240 |
|
|
2018
Q4 | $1.93M | Buy |
+52,299
| New | +$1.93M | ﹤0.01% | 977 |
|
|
2018
Q3 | – | Sell |
-11,510
| Closed | -$455K | – | 5545 |
|
|
2018
Q2 | $455K | Sell |
11,510
-12,262
| -52% | -$485K | ﹤0.01% | 2296 |
|
|
2018
Q1 | $612K | Sell |
23,772
-7,342
| -24% | -$189K | ﹤0.01% | 1922 |
|
|
2017
Q4 | $839K | Buy |
31,114
+23,041
| +285% | +$621K | ﹤0.01% | 1930 |
|
|
2017
Q3 | $302K | Buy |
+8,073
| New | +$302K | ﹤0.01% | 2485 |
|